Thompson Davis & CO. Inc. trimmed its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 48.1% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 2,800 shares of the pharmacy operator’s stock after selling 2,600 shares during the quarter. Thompson Davis & CO. Inc.’s holdings in Walgreens Boots Alliance were worth $216,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the business. Canada Pension Plan Investment Board boosted its stake in shares of Walgreens Boots Alliance by 0.3% during the 3rd quarter. Canada Pension Plan Investment Board now owns 2,123,913 shares of the pharmacy operator’s stock worth $164,009,000 after acquiring an additional 7,200 shares in the last quarter. Palouse Capital Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 74.5% during the 3rd quarter. Palouse Capital Management Inc. now owns 65,369 shares of the pharmacy operator’s stock worth $5,048,000 after acquiring an additional 27,912 shares in the last quarter. Heritage Investors Management Corp boosted its stake in shares of Walgreens Boots Alliance by 935.6% during the 3rd quarter. Heritage Investors Management Corp now owns 34,660 shares of the pharmacy operator’s stock worth $2,676,000 after acquiring an additional 31,313 shares in the last quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in shares of Walgreens Boots Alliance by 2.3% during the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 161,793 shares of the pharmacy operator’s stock worth $12,494,000 after acquiring an additional 3,681 shares in the last quarter. Finally, Northern Capital Management LLC boosted its stake in shares of Walgreens Boots Alliance by 89.8% during the 3rd quarter. Northern Capital Management LLC now owns 12,595 shares of the pharmacy operator’s stock worth $973,000 after acquiring an additional 5,960 shares in the last quarter. 61.41% of the stock is currently owned by institutional investors.

Several equities research analysts have recently issued reports on the stock. Needham & Company LLC lowered their target price on shares of Walgreens Boots Alliance to $86.00 and set a “buy” rating on the stock in a research note on Wednesday, November 22nd. Jefferies Group set a $93.00 target price on shares of Walgreens Boots Alliance and gave the stock a “buy” rating in a research note on Sunday, October 29th. Vetr raised shares of Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, December 12th. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Finally, Zacks Investment Research raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Thursday, October 5th. One research analyst has rated the stock with a sell rating, nine have given a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Buy” and a consensus target price of $86.47.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $71.94 on Friday. The company has a market cap of $72,850.00, a PE ratio of 13.80, a price-to-earnings-growth ratio of 1.25 and a beta of 1.22. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The company had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. Walgreens Boots Alliance’s quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.07 EPS. equities research analysts expect that Walgreens Boots Alliance Inc will post 5.54 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a $0.40 dividend. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.22%. Walgreens Boots Alliance’s payout ratio is 42.33%.

Walgreens Boots Alliance announced that its Board of Directors has initiated a share buyback program on Wednesday, October 25th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often a sign that the company’s board of directors believes its shares are undervalued.

In other Walgreens Boots Alliance news, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The stock was bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares in the company, valued at $3,350,000. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total transaction of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at approximately $1,105,878.55. The disclosure for this sale can be found here. 14.80% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.watchlistnews.com/thompson-davis-co-inc-sells-2600-shares-of-walgreens-boots-alliance-inc-wba/1769287.html.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with Analyst Ratings Network's FREE daily email newsletter.